Stereotactic Radiotherapy for Organ-confined Prostate Cancer: Early Toxicity and Quality of Life Outcomes from a Multi-institutional Trial

被引：6
|
作者：
Meier, R. [1 ]
Beckman, A. [2 ]
Kaplan, I. [3 ]
Mohideen, N. [4 ]
Shieh, E. [5 ]
Henning, G. [6 ]
Walz, B. [7 ]
Cotrutz, C. [1 ]
Sanda, M. [3 ]
机构：
[1] Swedish Canc Inst, Seattle, WA USA
[2] Cent Baptist Hosp, Lexington, KY USA
[3] Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA
[4] NW Community Hosp, Arlington Hts, IL USA
[5] Jupiter Med Ctr, Jupiter, FL USA
[6] St Joseph Mercy Hosp, Ypsilanti, MI USA
[7] St Louis Univ, St Louis, MO 63103 USA
来源：
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 2010年 / 78卷 / 03期
关键词：
D O I：
10.1016/j.ijrobp.2010.07.166
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S57 / S57
页数：1
相关论文
共 50 条
  • [21] Recurrence pattern of stereotactic body radiotherapy in oligometastatic prostate cancer: a multi-institutional analysis
    Nicosia, Luca
    Franzese, Ciro
    Mazzola, Rosario
    Franceschini, Davide
    Rigo, Michele
    D'agostino, Giuseppe
    Corradini, Stefanie
    Alongi, Filippo
    Scorsetti, Marta
    STRAHLENTHERAPIE UND ONKOLOGIE, 2020, 196 (03) : 213 - 221
  • [22] Stereotactic body radiotherapy boost toxicity for high and intermediate-risk prostate cancer: Report of a multi-institutional study
    Kaplan, Irving D.
    Appelbaum, Limor
    Aghdam, Nima
    Martin, Jarad
    Sidhom, Mark
    Pryor, David
    Aronovitz, Joseph A.
    Mahadevan, Anand
    Kennedy, Kevin F.
    Collins, Sean P.
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (06)
  • [23] Quality of Life Outcomes from a Phase I/II Multi-institutional, Dose-per-Fraction Escalation Trial for Prostate Cancer
    Brower, J. V.
    Forman, J. D.
    Kupelian, P. A.
    Gondi, V.
    Petereit, D. G.
    Lawton, C. A.
    Anger, N. J.
    Saha, S.
    Chappell, R. J.
    Ritter, M. A.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2014, 90 : S52 - S53
  • [24] Outcomes and Predictors of Organ-Confined Prostate Cancer Treated with Radiation Therapy
    Supit, W.
    Mochtar, C.
    Santoso, R.
    Umbas, R.
    UROLOGY, 2012, 80 (03) : S302 - S303
  • [25] Radiotherapy of organ-confined prostate cancer: Biochemical failure definitions and risk groups
    Thames, H
    RADIOTHERAPY AND ONCOLOGY, 2006, 78 : S28 - S28
  • [26] PERSPECTIVES ON THE ROLE OF RADIOTHERAPY IN ORGAN-CONFINED AND LOCALLY ADVANCED PROSTATE-CANCER
    PORTER, AT
    KACZOR, JG
    FORMAN, JD
    EUROPEAN UROLOGY, 1993, 24 : 39 - 43
  • [27] Preliminary results of a multi-institutional phase II trial of proton beam therapy for organ confined prostate cancer in Japan
    Nihei, K.
    Ogino, T.
    Onozawa, M.
    Murayama, S.
    Fuji, H.
    Murakami, M.
    Hishikawa, Y.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2008, 72 (01): : S291 - S291
  • [28] Health Outcomes and Quality of Life in a Multi-institutional Prospective Phase II Trial of Proton Radiotherapy for Pediatric Rhabdomyosarcoma
    Correia, D.
    Giblin, M.
    Bajaj, B.
    Lawell, M. P.
    Gallotto, S.
    Perry, A.
    Weyman, E. A.
    Paulino, A. C.
    Grosshans, D. R.
    McAleer, M. F.
    McGovern, S. L.
    Friedmann, A.
    Yeap, B. Y.
    MacDonald, S.
    Marcus, K. J.
    Tarbell, N. J.
    Yock, T. I.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2020, 108 (03): : S38 - S38
  • [29] Radical 3D-conformal radiotherapy and imrt of organ-confined prostate cancer
    Greco, C
    TUMORI, 2003, : S145 - S146
  • [30] Multi-institutional Prospective Evaluation of Quality of Life Outcomes in Patients Treated With Proton Therapy for Prostate Cancer
    Hartsell, W. F.
    Chang, A.
    Chang, J. H. C.
    Larson, G.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2014, 90 : S458 - S458
12345